Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-028865
Filing Date
2018-06-15
Accepted
2018-06-15 19:08:52
Documents
1
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5958
  Complete submission text file 0001140361-18-028865.txt   7369
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARDELYX, INC. 34715 ARDENWOOD BLVD, SUITE 100 FREMONT CA 94555
Business Address
Jenkins Annalisa (Reporting) CIK: 0001639481 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 18903391